Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions

Cancer Letters

Volumn 105, Issue 2, 1996, Pages 139-146

  Ravi, D ^a   Nalinakumari, K R ^a   Rajaram, R S ^a   Nair, M Krishnan ^b   Pillai, M Radhakrishna ^a  

^a REGIONAL CANCER CENTRE   (India)

^b Medical College Hospital   (India)

Author keywords

bcl 2; Immunocytochemical evaluation; Oral cancer; p53

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER INVASION; CONTROLLED STUDY; DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MOUTH CANCER; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; TOBACCO;

EID: 0030565001     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04258-9     Document Type: Article

References (27)

1. [1] Eneroth, C.M. and Moberger, G. (1973) Histological malignancy grading of squamous cell carcinoma of the palate. Acta Otolaryngol., 75, 293-295.
2. [2] Finlay, C.S., Hinds, P.W., Tan, T.H., Eliyahau, D., Oren, M. and Levine, A.J. (1988) Activating mutations for transformation by p53 produce a gene product that forms a hsc70-p53 complex with altered half life. Mol. Cell. Biol., 8, 531-539.
3. [3] Hollstein, M., Sidransky, D., Volgestein, B. and Harris, C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
4. [4] Jayanth, K. and Notani, M. (1991) Epidemiology of oral cancer. In: Oral Cancer, pp. 1-7. Editors: R.S. Rao and P.B. Desai. Professional Education Division, Tata Memorial Hospital, Bombay.
5. [5] Kaur, J., Srivastava, A. and Ralhan, R. (1994) Overexpression of p53 protein in betal and tobacco related human oral dysplasia and squamous cell carcinoma in India. Int. J. Cancer, 58, 340-345.
6. [6] Krajeswski, S., Tanaka, S. and Takayama, S. (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein in the nuclear envelope, endoplasmic reticulum and outer mitochondrial membranes. Cancer Res., 53, 4701-4714.
7. [7] Kuttan, N.A.A., Rosin, M.P., Ambika, K., Priddy, R.W., Bhakthan, N.M.G. and Zhang, L. (1995) High prevalence of expression of p53 oncoprotein in oral carcinomas from India associated with betel and tobacco chewing. Oral Oncol., Eur. J. Cancer, 31B, 169-173.
8. [8] Lane, D.P. (1992) p53 - guardian of the genome. Nature, 358, 15-16.
9. [9] Levine, A.J., Momand, J. and Finlay, C.A. (1991) The p53 tumor suppressor gene. Nature, 319, 783-784.
10. [10] Liang, X.H., Mungal, S., Ayscue, A., Meissner, J.D., Wodnicki, P., Hockenberry, D., Lockett, S. and Herman, B. (1995) Bcl-2 protooncogene expression in cervical carcinoma cell lines containing inactive p53. J. Cell Biochem., 57, 509-520.
11. [11] McDonnel, T.J., Troncoso, P. and Brisbay, S.M. (1991) Bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57, 79-88.
12. [12] McDonnell, T.J., Marin, M.C., Brisbay, B.H., McConnell, K., Tu, S.M., Cambell, M.L. and Rodriguez-Villanueva, J. (1993) The bcl-2 oncogene, apoptosis and neoplasia. Radiat. Res., 136, 307-312.
13. [13] McKalip, A., Pillai, M.R., Halabi, S., Hockenberry, D. and Herman, B. (1995) Apoptosis and cervical cancer. 14th Int. Papillomavirus Conf., Abstract.
14. [14] Nishioka, H., Hiasa, Y., Hayashi, I., Kitahori, Y., Konishi, N. and Sugimura, M. (1993) Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings. Oncology, 50, 426-429.
15. [15] Ogden, G.R., Lane, D.P. and Chisholm, D.M. (1993) p53 expression in dyskeratosis congenita: a marker for oral premalignancy. J. Clin. Pathol., 46, 169-170.
16. [16] Oren, M., The involvement of oncogenes and tumor suppressor genes in the control of apoptosis (1993) Cancer Metastasis Rev., 11, 141-148.
17. [17] Oren, O. (1992) p53: the ultimate tumor suppressor gene? FASEB J., 6, 3169-3176.
18. [18] Ranasinghe, A.W., Warnakulasuriya, K.A.A.S. and Johnson, N.W. (1993) Low prevalence of expression of p53 oncoprotein in oral carcinomas from Sri Lanka with betal and tobacco chewing. Oral Oncol., Eur. J. Cancer, 29B, 147-150.
19. [19] Sankaranarayanan, R., Nair, M.K., Mathew, B., Balaram, P., Sebastian, P. and Dutt, S.C. (1992) Recent results in oral cancer research in Kerala. Head Neck, 14, 107-112.
20. [20] Shaw, P., Bowley, T. and Tanders, S. (1992) Induction of apoptosis by wild type p53 in a human colon tumor derived cell line. Proc. Natl. Acad. Sci. USA, 89, 4995-4999.
21. [21] Steller, H. (1995) Mechanisms and genes of cellular suicide. Science, 86, 1445-1462.
22. [22] Stewart, B.W. (1994) Mechanisms of apoptosis: integration of genetic, biochemical and cellular indicators. J. Natl. Cancer Inst., 86, 1286-1296.
23. [23] Ullrich, S.J., Anderson, C.W. and Mercer, W.E. (1992) The p53 tumor suppressor protein: a modulator of cell proliferation. J. Biol. Chem., 267, 1529-1562.
24. [24] Van den Berg, F.M., Baas, I.O., Polak, M.M. and Offerhaus, G.J.A. (1993) Detection of p53 overexpression in routinely fixed paraffin embedded tissue of human carcinomas using a novel target unmasking fluid. Am. J. Pathol., 142, 381-385.
25. [25] WHO Collaborating Centre For Oral Pre-Cancerous Lesions (1978) Definition of leukoplakia and related lesions: an aid to studies on oral pre-cancer. Oral Surg., 46, 518-539.
26. [26] Wynford-Thomas, D. (1991) Oncogenes and anti-oncogenes: the molecular basis of tumour behaviour. J. Pathol., 165, 187-201.
27. [27] Zatterstrom, U., Wennerberg, J., Ewers, S.B., Willen, R. and Attewell, R. (1991) Prognostic factors in head and neck cancer: histologie grading, DNA ploidy and nodal status. Head Neck, 13, 477-487.